source
- Novartis expands molecular glue program as Medicare drug spending surges and biotech firms report new data and fundingNovartis announced it is deepening its investment in molecular glue technology, a platform that aims to target previously undruggable proteins. The move signals the company’s confidence in the appr…
- FDA grants emergency use authorization for generic Nitenpyram tablets to treat New World screwworm in dogs and catsThe U.S. Food and Drug Administration has issued an Emergency Use Authorization for generic Nitenpyram tablets to treat New World screwworm infestations in dogs, puppies, cats and kittens that weig…